MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region. Research focuses on how it participates in communication between mitochondria and the nucleus under metabolic or cellular stress. That mechanism is still an active research area, not proof of a general anti-aging outcome.
- MOTS-c is encoded by mitochondrial DNA and contains 16 amino acids.
- Mechanistic, animal and human evidence should be labeled separately.
- A catalog strength is a product attribute, not an experimental recommendation.
Why MOTS-c is called a mitochondrial-derived peptide
Most familiar peptides are encoded in nuclear genes. MOTS-c is unusual because its sequence comes from a short open reading frame within mitochondrial 12S rRNA. Reviews describe stress-related movement to the nucleus and links to gene regulation, but the exact response depends on model, tissue and experimental conditions.
Evidence map for MOTS-c research
| Evidence layer | Typical question | Safe interpretation |
|---|---|---|
| Cell studies | Which pathways or genes respond? | Mechanistic signal under defined laboratory conditions |
| Animal studies | How does the response appear across tissues? | Preclinical finding, not automatic human translation |
| Human observations | How do circulating levels associate with age or phenotype? | Association does not prove intervention benefit |
How to compare MOTS-c catalog entries
- Confirm the full name behind the MOTS-c abbreviation.
- Record the listed strength per vial and vial count.
- Check whether the material is single-compound or blended.
- Keep catalog specifications separate from methods in a cited paper.
- Request lot documentation when the study requires it.
Researchers can open the Cellular & Longevity Research collection and review the MS10 MOTS-c listing. The product title expands MOTS-c as “mitochondrial open reading frame of the 12S rRNA-c,” which helps preserve identity in procurement records.
What MOTS-c research cannot establish by itself
A mitochondrial signaling mechanism does not prove that a commercial material extends lifespan, treats disease or produces a predictable human outcome. Reviews describe promising preclinical biology and open questions. Final conclusions require matched material, validated methods and controlled evidence.
For SKU conventions, read How to Read NOVABIO Product Names. Product-specific questions can go to NOVABIO support.
Frequently asked questions
What is MOTS-c?
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region. Researchers study its role in stress-responsive signaling, gene regulation and metabolism. Much of the mechanistic evidence is preclinical, so the peptide’s biological interest should not be rewritten as a guaranteed human outcome.
Is MOTS-c the same as NAD+?
No. MOTS-c is a peptide with a defined amino-acid sequence. NAD+ is nicotinamide adenine dinucleotide, a small-molecule coenzyme involved in redox reactions and signaling. Both appear in cellular and longevity research, but their chemical identities, pathways and analytical methods are different.
How should a MOTS-c listing be documented?
Record the full compound name, MOTS-c abbreviation, listed mass per vial, vial count, SKU, product form and lot-specific documentation. Do not treat the listed milligrams as a protocol recommendation, and do not transfer findings from a paper unless the studied material and methods match.
Sources
- PubMed: MOTS-c, stress, metabolism and aging (accessed 2026-08-27)
- PubMed: MOTS-c and human aging (accessed 2026-08-27)
- PubMed: mitochondrial-encoded peptides (accessed 2026-08-27)
Research-use notice: This article explains catalog identity and published research. It is not medical advice, a treatment claim or a dosing guide. NOVABIO catalog products are presented for laboratory research and are not represented here as approved for human use.
USD